A randomised, double-blinded, placebo-controlled study evaluating the efficacy and safety of nabilone as an adjunctive to gabapentin in managing multiple sclerosisinduced neuropathic pain

Authors
Category Primary study
ConferenceMultiple Sclerosis
Year 2011
This article has no abstract
Epistemonikos ID: 7fe95efd5e06508e35fe63ec00a2421665ff58ae
First added on: Mar 13, 2018